BENU
ActiveSummary
BENU has been active since 1989 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €43.1m and a net result of €1.4m. Equity has been growing by about 10% per year since 2019. Its solvency ranks better than 66% of 372 sector peers (NACE 47, financial year 2026). The computed 12-month bankruptcy probability is 0.3% (very low).
Overview
Official details
Source: KBO- Status
- Active since 08-02-1989 Normal situation
- Registered office
- 27 active companies are registered at this address Source: KBO register, as of 3 November 2026.
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Joint committee
- 313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 31-01-2026
- Establishment units
- 2.006.356.611 9000 Gent, since 01-03-1961
- 2.006.299.005 1030 Schaarbeek, since 01-01-1963and 110 others
- Financial year end
- 31 January
- Peppol
- Reachable since 10-06-2025
Board and ownership
- Auditor
- Forvis Mazars Réviseurs d'Entreprises SRL/Bedrijfsrevisoren BV
- BENU Management100%· score 83annual accounts 31-01-2026
- PHOENIX International Holdings GmbHconsolidatesannual accounts 31-01-2026
- Holdings
- Shares in 1 company M.D.D. PHARMA
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.3%
- Turnover
- €172.2m
- ▲ 3.5%
- Profit
- €1.4m
- ▼ 13.0%
- Equity
- €43.1m
- ▲ 12.4%
- Total assets
- €84.1m
- ▲ 36.1%
- Employees on 31-01-2026
- 442
- ▼ 1.1%
Score breakdownraises riskLiquidity: current ratio 1.39, cash €992,585Sector: Retail trade (NACE 47)lowers riskFounded in 1989Legal form: public limited companyShow the evidence
Checked score
About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, large). It does better than 83% of them on solvency, 45% on liquidity, 43% on profitability and 65% on growth.
The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 41 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
- Positive: Largest employer in Wavre, Wholesale and retail trade sectorin the Checked rankings No. 1 View
- 8 restructurings since 2024latest: merger with APOTEEK KELLES 8 View
- Positive: Filed on time since financial year 2019accounts within the deadline every year 8 years View
- Positive: 8 profitable years in a rowprofit 2026: €1.4m 8 years View
Recent changes
- · Gazette deed Merger: BENU takes over АРОТЕЕК KELLESCapital increase of €18,600 to €94,347,034.30
- · Gazette deed Merger: BENU takes over APOBELLECapital increase of €1,860 to €94,328,434.30
- · Gazette deed Reappointments: An Marin, Arnaud Berken and Philippe Lacroix
Comparable companies
These companies have the same main activity as BENU: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €31m and €171m, founded between 1913 and 2014.
| Company | Total assets | Turnover |
|---|---|---|
| BENU Wavre | €84.1m | €172.2m |
| TILMAN Somme-Leuze | €43.2m | €58.2m |
| PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT Thimister-Clermont | €73.8m | €109.5m |
| COOP-APOTHEKEN Gent | €31.2m | €85.3m |
| L'Economie Populaire Ciney | €114.7m | €172.9m |
| MEDI-MARKET Parapharmacies Evere | €171.3m | €326.6m |
| UNIVERSAL PHARMA Frameries | €31.5m | €51.5m |
Key facts about BENU
- What is the company number of BENU?
- The company number of BENU is 0436.826.929. The VAT number is the same number with BE in front: BE 0436.826.929.
- Where is BENU based?
- The registered office is at Avenue Pasteur 2, 1300 Wavre.Company details
- What does BENU do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of BENU?
- The legal form of BENU is Public limited company (NV).
- When was BENU founded?
- BENU was founded on 08-02-1989.
- Is BENU still active?
- Yes, BENU is an active enterprise in the KBO register.
- How many employees does BENU have?
- BENU had an average of 370.2 full-time equivalents in financial year 2026, according to the filed annual accounts.Financials
- Which joint committee does BENU fall under?
- In its 31-01-2026 annual accounts, BENU states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
- What is the turnover of BENU?
- The turnover of BENU was €172.2m in financial year 2026, according to the filed annual accounts.
- Is BENU profitable?
- In financial year 2026, BENU made a profit of €1.4m.
- Where can I find the annual accounts of BENU?
- BENU filed 37 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
- When are the next annual accounts of BENU due?
- BENU must file the annual accounts for financial year 2027 by 31-08-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.